Acorda Therapeutics files $150 million shelf registration

By E. Janene Geiss

Philadelphia, May 30 - Acorda Therapeutics, Inc. filed a $150 million shelf registration in an S-3 filing with the Securities and Exchange Commission.

The registration covers common stock, preferred stock, debt securities, warrants and units. The securities may be structured as convertibles.

A secondary offering includes the sale of 1.367 million shares by selling shareholders, including 67,476 common shares issuable upon conversion of outstanding convertible notes. The company will not receive proceeds from the sale of units by the selling shareholders.

The Hawthorne, N.Y., biopharmaceutical company will use proceeds for general corporate purposes.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.